Teva (Israel) Richard Francis New CEO – D/E

Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023.

In order to ...

Please register here, or login below.